Abivax Sa ADR (ABVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -380,266 | -297,067 | -114,410 | -55,172 | -190,712 |
| Depreciation Amortization | 1,213 | 930 | 595 | 288 | 1,190 |
| Income taxes - deferred | 6,616 | N/A | N/A | N/A | N/A |
| Accounts receivable | 7,967 | -2,690 | 2,596 | -2,277 | N/A |
| Accounts payable and accrued liabilities | -7,026 | -16,669 | 15,595 | 13,436 | N/A |
| Other Working Capital | 125,232 | 15,647 | 17,551 | 9,493 | 3,072 |
| Other Operating Activity | 63,962 | 138,655 | 2,448 | -827 | 19,729 |
| Operating Cash Flow | $-182,301 | $-161,193 | $-75,625 | $-35,058 | $-166,721 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -161 | -64 | -72 | -46 | -693 |
| Other Investing Activity | -9,109 | 5,382 | 1,512 | 1,186 | 17,749 |
| Investing Cash Flow | $-9,270 | $5,317 | $1,441 | $1,140 | $17,056 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,476 | -2,558 | -2,484 | -2,305 | N/A |
| Common Stock Issued | 739,872 | 760,710 | N/A | N/A | N/A |
| Other Financing Activity | -118,174 | -72,175 | -16,365 | -5,951 | 30,523 |
| Financing Cash Flow | $619,223 | $685,977 | $-18,849 | $-8,256 | $30,523 |
| Exchange Rate Effect | -11,598 | -10,450 | -2,026 | -738 | 2,578 |
| Beginning Cash Position | 163,172 | 168,580 | 163,720 | 151,937 | 272,626 |
| End Cash Position | 584,577 | 689,304 | 69,186 | 109,117 | 156,062 |
| Net Cash Flow | $421,406 | $520,723 | $-94,534 | $-42,820 | $-116,565 |
| Free Cash Flow | |||||
| Operating Cash Flow | -182,301 | -161,193 | -75,625 | -35,058 | -166,721 |
| Capital Expenditure | -161 | -64 | -72 | -46 | N/A |
| Free Cash Flow | -182,462 | -161,257 | -75,696 | -35,105 | -166,721 |